Plandaí Biotechnology, Inc. (PLPL)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Jul 18, 2025, 4:00 PM EDT
Plandaí Biotechnology Company Description
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.
It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis.
The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa.
Plandaí Biotechnology, Inc. is based in London, the United Kingdom.
Plandaí Biotechnology, Inc.
| Country | United States |
| Industry | Shell Companies |
| Sector | Financials |
| Employees | 180 |
| CEO | Roger Baylis-Duffield |
Contact Details
Address: 17 Hanover Square London, Nevada W1S 1BN United Kingdom | |
| Phone | 44 91 7900 9829 |
| Website | plandaibiotech.com |
Stock Details
| Ticker Symbol | PLPL |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US72703D1000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Roger Baylis-Duffield | Co-Founder, Chairman and Chief Executive Officer |
| Callum Baylis-Duffield | President, Chief Operating Officer and Director |
| Ezra Jones | Vice President of Sales and Marketing |